MIRA
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$0.52
-3.61% today
Updated 2026-11-03
Market cap
$26.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.3
Quality
B3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
1.9
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →252 stocks currently score above 75
Price targets
Analyst target
$3.50
+575.94%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-1.21M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-7.06M | $-11.98M | $-7.85M | $-10.44M | $-1.21M |
| EPS | — | — | — | — | $-1.14 |
| Free cash flow | $-5.60M | $-4.53M | $-5.56M | $-4.66M | $-1.21M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
MIRA Pharmaceuticals, Inc. Common Stock trades at $0.52. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.88, it sits in the grey zone.
Frequently asked questions
What is MIRA Pharmaceuticals, Inc. Common Stock's stock price?
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) trades at $0.52.
Is MIRA Pharmaceuticals, Inc. Common Stock overvalued?
MIRA Pharmaceuticals, Inc. Common Stock carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of MIRA Pharmaceuticals, Inc. Common Stock (MIRA)?
The 12-month analyst consensus target is $3.50, about 575.9% above the current $0.52. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
MIRA Pharmaceuticals, Inc. Common Stock's Altman Z-Score is 1.88, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-104.92%
Beta1.49
50D MA$0.76
200D MA$0.99
Shares out0.04B
Float0.04B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—